Skip to content

Author

Mariah Eisner

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Real-world Efficacy, Safety and Heterogenicity of Efficacy of Elexacaftor-Tezacaftor-Ivacaftor in Younger Children (6-11 Years Old) with Cystic Fibrosis.

ETI therapy was associated with improved clinical outcomes in younger children, and heterogenicity was noted in effectiveness, and significant improvements were noted in pulmonary exacerbations, hospital admissions, antibiotic courses, and number of chCF receiving daily chest therapy.

Shahid I. Sheikh, Melissa Holtzlander, Mariah Eisner et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.